IOBT Q4 2024 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena

IOBTIO Biotech, Inc.

$21M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$219,000

Operating Income

-$27M

Net Income

-$31M

EPS (Diluted)

$-0.48

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$68M

Total Liabilities

$21M

Stockholders' Equity

$47M

Cash & Equivalents

$60M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$219,000	-$201,000	-9.0%
Operating Income	-$27M	-$28M	+4.4%
Net Income	-$31M	-$26M	-19.7%